Osteo-Pharma focusses on the development of new therapies to improve the healing of bone fractures (open or closed), bone defects e.g. as consequence of trauma or cancer, osteo-arthritis and the development of coatings for implants to improve osseo-integration.

Upon successful (pre-) clinical development Osteo-Pharma is seeking partnerships with pharma and medical device companies to co-develop products for the European and US markets.